FCM
Fourpath Capital Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $893K | Buy |
36,855
+6,095
| +20% | +$148K | 0.14% | 101 |
|
|
2025
Q1 | $779K | Buy |
30,760
+7,987
| +35% | +$202K | 0.14% | 101 |
|
|
2024
Q4 | $604K | Sell |
22,773
-5,328
| -19% | -$141K | 0.11% | 123 |
|
|
2024
Q3 | $813K | Buy |
28,101
+3,425
| +14% | +$99.1K | 0.15% | 102 |
|
|
2024
Q2 | $690K | Sell |
24,676
-780
| -3% | -$21.8K | 0.51% | 47 |
|
|
2024
Q1 | $706K | Buy |
25,456
+2,838
| +13% | +$78.8K | 0.49% | 49 |
|
|
2023
Q4 | $651K | Sell |
22,618
-967
| -4% | -$27.8K | 0.44% | 47 |
|
|
2023
Q3 | $782K | Sell |
23,585
-504
| -2% | -$16.7K | 0.59% | 36 |
|
|
2023
Q2 | $884K | Buy |
24,089
+3,162
| +15% | +$116K | 1.06% | 27 |
|
|
2023
Q1 | $854K | Buy |
20,927
+3,933
| +23% | +$160K | 0.6% | 35 |
|
|
2022
Q4 | $871K | Buy |
16,994
+2,218
| +15% | +$114K | 0.63% | 39 |
|
|
2022
Q3 | $647K | Sell |
14,776
-966
| -6% | -$42.3K | 0.44% | 53 |
|
|
2022
Q2 | $825K | Sell |
15,742
-1,619
| -9% | -$84.8K | 0.51% | 45 |
|
|
2022
Q1 | $899K | Buy |
17,361
+4,023
| +30% | +$208K | 0.36% | 51 |
|
|
2021
Q4 | $788K | Buy |
+13,338
| New | +$788K | 0.3% | 63 |
|